Talking nuclear fusion
Dr Richard Garrett featured on an ABC National program that highlighted how far we are from a future with nuclear fusion energy. Image: Jamison Daniel, Oak Ridge Leadership Computing Facility
Showing 1981 - 2000 of 2722 results
Searching for skyrmions
Neutron scattering helps clarify the arrangement of magnetic vortices, skyrmions, in material
Transforming waste coffee grounds into next generation batteries
Evidence of spin nematic
Evidence for existence of a highly exotic and elusive state of matter, known as a magnetic ‘spin nematic’ phase in a natural mineral called linarite.
Year 11 Chemistry Online Learning
Participate in live radiation demonstrations, cover syllabus content and visit ANSTO virtually during our online depth study classes for Year 11 Chemistry.
- Investigate properties of different radioisotopes and learn about their uses in medicine, industry and environmental research.
- Consider the scientific method and gather data during a live radiation experiment.
- See some of Australia's largest scientific infrastructure, including the OPAL multipurpose reactor.
Cost: $90 per class.
Year 7-8 In Their Elements Online Learning
Bring the periodic table to life in this interactive videoconference lesson.
Students see real samples of common elements, learn about their history, properties and uses, and find out how the periodic table was developed during the 19th century.
Students review atomic structure, elements and the organisation of today's periodic table, before applying their knowledge and skills in a fun periodic table game.
Cost: $90 per class.
Investigating radiation in the air we breathe
Radon is a significant component of background radiation and can accumulate in poorly ventilated indoor environments.
In this data set, we investigated the effect of electrostatically charging a balloon, which was then hung in an enclosed space, on its level of radioactivity.
Students write a hypothesis, graph data, write a conclusion and use provided information to answer questions about radioactivity and radon, experimental design, accuracy, validity and reliability.
Australian Synchrotron FAQs
Frequently asked questions about beamtime, accommodation and the user portal.
Research supports potential local supply chain for component in COVID PCR test
University of Melbourne researchers have investigated a method to produce magnetic nanoparticles in Australia for use in COVID-19 PCR tests.
Stephen Wilkins Medal
Applications open for 2017 ANSTO Australian Synchrotron Stephen Wilkins Medal
2017 ANSTO, Australian Synchrotron Stephen Wilkins Medal
Nominations are being accepted for the 2017 Stephen Wilkins medal for an outstanding thesis.
Hijacker parasite blocked from infiltrating blood
International collaboration uses Australian Synchrotron on pioneering malaria research.
Radiation measurement
ANSTO maintains national capabilities in radionuclide metrology, the measurement and detection of ionising radiation, radioanalytical chemistry and nuclear forensics to support industry, government and scientific users.
ANSTO team presents at the IAEA’s Train-the-Trainers Regional Training Course for Radiation Protection Officers in Vienna
Staff from ANSTO’s High Reliability team, Prashant Maharaj, Tina Paneras, and Sam Sonter were honoured to present at the International Atomic Energy Agency’s (IAEA) Train-the-Trainers Regional Training Course for Radiation Protection Officers in Vienna, Austria on 16 to 20 January 2023.
Equipment - Energy Materials
Infastructure used on the Energy Materials Project.
Technical information - Echidna
Specifications and Instrument references.
Nuclear medicine production at ANSTO
Media statement from ANSTO.
Research on nickel
Study reveals that properties of polycrystalline materials can be derived from microscopic single crystal samples
Highlights - Planetary Materials
Planetary science is an emerging research theme in Australia, and research at ANSTO is embedded in the heart of this.
License to produce Lutetium-177 for clinical trials
ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.